Procter & Gamble Hygiene and Health Care Limited (PGHH) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Procter & Gamble Hygiene and Health Care Limited (PGHH) enters its Q1 FY27 results following a flat FY26 top-line performance, with investors looking for signs of volume recovery amid a complex macro environment. The upcoming print will likely focus on the company's ability to navigate crude-linked input cost headwinds through its productivity program and the impact of a delayed monsoon on its Vicks healthcare portfolio.

Procter & Gamble Hygiene and Health Care Limited Q1 Results Date and Time

The Board of Directors is scheduled to meet on July 29, 2026, to consider and approve the unaudited financial results for the first quarter of FY 2026-2027.

What to expect from Procter & Gamble Hygiene and Health Care Limited's Q1 FY27 results

The company's top-line trajectory is expected to be tested against the 8.4% gross GST growth observed in Q1 FY27, which provides a more constructive macro backdrop than the flat revenue performance seen in FY26. While the feminine hygiene category maintains a structural growth rate of 7–10%, the healthcare portfolio's dependence on the monsoon suggests that the delayed June onset may have compressed demand, with late-quarter rainfall in key markets like Mumbai and Gujarat serving as a potential offset. Management's ability to protect margins will be the central focus, as the company faces a distinct input-cost headwind with Brent crude averaging well above the $82.22/barrel baseline throughout the quarter. The systematic productivity program, which delivered Rs. 86 Cr in savings last year, remains the primary lever to mitigate these inflationary pressures. Investors will also be monitoring the debut call of the new CFO, Ms. Srividya Srinivasan, for any shifts in guidance philosophy or capital allocation priorities.

Key Things To Watch

Top-line growth trajectory: Monitoring revenue recovery versus the flat performance of FY26.

• Assess volume versus value growth trends in Q1 FY27.
• Evaluate the impact of the late-June monsoon surge on the Vicks healthcare segment revenue.

Productivity savings and margin management: Tracking the primary offset to crude-linked input cost inflation.

• Update on FY27 savings targets following the Rs. 86 Cr delivered in FY26.
• Status of multi-year savings master plans across business units.

Competitive dynamics in Feminine Hygiene: Addressing analyst concerns regarding market share and promotional intensity.

• Commentary on pricing pressure and promotional intensity in the feminine hygiene segment.
• Market share trends for the Whisper brand portfolio.

Leadership transition: Observing the impact of new executive appointments on company strategy.

• First earnings call commentary from new CFO Ms. Srividya Srinivasan.
• Transitional commentary regarding the new Sales Head and VP of Feminine Hygiene effective August 1, 2026.